A human trial to evaluate effects of ginsenoside fortified red ginseng on immune function and fatigue recovery

A single-center, randomized, double-blind, placebo-controlled pilot human trial to evaluate effects of 4-week administration of ginsenoside fortified red ginseng on immune function and fatigue recovery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001647

Enrollment

Registered

2015-10-05

Start date

2015-01-12

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Treatment group: ginsenoside fortified red ginseng, 1000mg , twice a day, for 4 weeks, oral administration Control group: placebo capsule(ginseng flavored wheat flour), 1000mg, tw

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Aged between 55 and 80 years 2)People whose Health Practice Index is over 3: exercise mre than once a week, no smoking, drinking under once a week, body mass index(20-25), sleep fro 7-8 hours 3)People whose fatigue is over 30 in visual analogue scale(VAS) 4)People who are mentally healthy and can obey the rules of this study 5)People who voluntarily join this study and sign the written consent form

Exclusion criteria

Exclusion criteria: 1)People who should be administered western medicine(except who suffer hypertension and diabetes mellitus) 2)People who suffer infectious disease and should be severely treated 3)Night workers 4)People who cannot obey the rules of this study owing to physiological and psychological problems 5)People who are allergic to ginseng and red ginseng

Design outcomes

Primary

Measure	Time frame
NK cell activity	—

Secondary

Measure	Time frame
quality of life(short form healthy survey: SF-36);fatigue scale(Revised Piper Fatigue Scale, Visual Analogue Scale);blood test(neutrophyl activity, erythrocyte sedimentation rate(ESR), c-reactive protein(CRP), fibrinogen)	—

Countries

Korea, Republic of

Contacts

Public ContactHwa Seung Yoo

Dunsan Korean Medicine Hospital of Daejeon University

altyhs@hanmail.net

Outcome results